Potential Role of Oral Anthracyclines in Older Patients with Cancer
- 1 May 1994
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 4 (5) , 392-402
- https://doi.org/10.2165/00002512-199404050-00004
Abstract
Two anthracycline analogues, idarubicin and menogaril, have acceptable bioavailability via the oral route of administration. Encouraging antitumour activity of oral idarubicin has been reported in...Keywords
This publication has 73 references indexed in Scilit:
- Perspectives on Quality of Life of Older Patients with CancerDrugs & Aging, 1994
- Oral idarubicin — an anthracycline derivative with unique propertiesAnnals of Hematology, 1993
- Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- A phase II trial of oral idarubicin plus dibromodulcitol in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Evaluation of cardiac toxicity of idarubicin (4-demethoxydaunorubicin)European Journal of Cancer and Clinical Oncology, 1989
- Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive daysEuropean Journal of Cancer and Clinical Oncology, 1988
- A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myelomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Chemotherapy in the elderlyEuropean Journal of Cancer and Clinical Oncology, 1987
- Non-Hodgkin's lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patientsEuropean Journal of Cancer and Clinical Oncology, 1987
- New anthracycline analogs in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986